Free Trial

Evaxion A/S (EVAX) Competitors

Evaxion A/S logo
$2.92 -0.02 (-0.68%)
Closing price 09/15/2025 04:00 PM Eastern
Extended Trading
$2.88 -0.04 (-1.37%)
As of 09/15/2025 04:45 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

EVAX vs. CARM, IXHL, NBY, NRSN, BLRX, ATHA, NERV, CYCC, ETHZ, and COCP

Should you be buying Evaxion A/S stock or one of its competitors? The main competitors of Evaxion A/S include Carisma Therapeutics (CARM), Incannex Healthcare (IXHL), NovaBay Pharmaceuticals (NBY), NeuroSense Therapeutics (NRSN), BioLineRx (BLRX), Athira Pharma (ATHA), Minerva Neurosciences (NERV), Cyclacel Pharmaceuticals (CYCC), Flag Ship Acquisition (ETHZ), and Cocrystal Pharma (COCP). These companies are all part of the "pharmaceutical products" industry.

Evaxion A/S vs. Its Competitors

Evaxion A/S (NASDAQ:EVAX) and Carisma Therapeutics (NASDAQ:CARM) are both small-cap medical companies, but which is the better stock? We will contrast the two companies based on the strength of their institutional ownership, analyst recommendations, profitability, risk, dividends, earnings, media sentiment and valuation.

Evaxion A/S has higher earnings, but lower revenue than Carisma Therapeutics. Evaxion A/S is trading at a lower price-to-earnings ratio than Carisma Therapeutics, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Evaxion A/S$3.34M1.22-$10.57M-$1.32-2.21
Carisma Therapeutics$19.63M0.74-$60.48M-$1.56-0.22

Carisma Therapeutics has a net margin of -254.28% compared to Evaxion A/S's net margin of -316.03%. Carisma Therapeutics' return on equity of 0.00% beat Evaxion A/S's return on equity.

Company Net Margins Return on Equity Return on Assets
Evaxion A/S-316.03% -319.52% -63.56%
Carisma Therapeutics -254.28%N/A -192.17%

Evaxion A/S has a beta of 0.14, indicating that its share price is 86% less volatile than the S&P 500. Comparatively, Carisma Therapeutics has a beta of 1.82, indicating that its share price is 82% more volatile than the S&P 500.

Evaxion A/S presently has a consensus target price of $10.00, suggesting a potential upside of 242.47%. Carisma Therapeutics has a consensus target price of $1.93, suggesting a potential upside of 456.68%. Given Carisma Therapeutics' higher probable upside, analysts plainly believe Carisma Therapeutics is more favorable than Evaxion A/S.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Evaxion A/S
0 Sell rating(s)
0 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
3.00
Carisma Therapeutics
0 Sell rating(s)
4 Hold rating(s)
1 Buy rating(s)
2 Strong Buy rating(s)
2.71

11.0% of Evaxion A/S shares are held by institutional investors. Comparatively, 44.3% of Carisma Therapeutics shares are held by institutional investors. 41.6% of Evaxion A/S shares are held by company insiders. Comparatively, 6.9% of Carisma Therapeutics shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.

In the previous week, Carisma Therapeutics had 1 more articles in the media than Evaxion A/S. MarketBeat recorded 3 mentions for Carisma Therapeutics and 2 mentions for Evaxion A/S. Evaxion A/S's average media sentiment score of 1.89 beat Carisma Therapeutics' score of 0.45 indicating that Evaxion A/S is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Evaxion A/S
0 Very Positive mention(s)
1 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Very Positive
Carisma Therapeutics
0 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

Summary

Carisma Therapeutics beats Evaxion A/S on 9 of the 17 factors compared between the two stocks.

Get Evaxion A/S News Delivered to You Automatically

Sign up to receive the latest news and ratings for EVAX and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding EVAX and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

EVAX vs. The Competition

MetricEvaxion A/SMEDICAL INFO SYS IndustryMedical SectorNASDAQ Exchange
Market Cap$4.13M$2.16B$5.80B$10.17B
Dividend YieldN/AN/A5.72%4.61%
P/E Ratio-2.2135.4275.0526.39
Price / Sales1.2210.20544.00190.24
Price / CashN/A58.5825.8129.91
Price / Book-2.4711.5813.436.28
Net Income-$10.57M-$63.67M$3.29B$270.38M
7 Day Performance4.29%-1.82%0.08%1.89%
1 Month Performance1.39%1.84%4.61%6.01%
1 Year Performance-82.03%36.11%75.02%25.26%

Evaxion A/S Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
EVAX
Evaxion A/S
2.6349 of 5 stars
$2.92
-0.7%
$10.00
+242.5%
-80.5%$4.13M$3.34M-2.2160News Coverage
Positive News
Gap Up
CARM
Carisma Therapeutics
2.6291 of 5 stars
$0.38
-4.8%
$1.93
+409.3%
-66.1%$15.80M$19.63M-0.2420News Coverage
Short Interest ↑
IXHL
Incannex Healthcare
0.1448 of 5 stars
$0.54
-7.2%
N/A-67.5%$15.69M$10K-0.443Short Interest ↑
Gap Up
NBY
NovaBay Pharmaceuticals
0.4038 of 5 stars
$2.67
-1.1%
$0.85
-68.2%
+477.0%$15.55M$9.78M-0.0530Gap Up
NRSN
NeuroSense Therapeutics
2.5748 of 5 stars
$1.12
-3.4%
$14.00
+1,150.0%
-14.1%$15.38MN/A-2.0810
BLRX
BioLineRx
3.3312 of 5 stars
$3.59
-1.5%
$26.00
+625.2%
-84.9%$15.28M$28.94M-0.4140Positive News
ATHA
Athira Pharma
3.0128 of 5 stars
$0.38
-1.0%
$0.50
+31.2%
-27.3%$15.22MN/A-0.2540
NERV
Minerva Neurosciences
3.7698 of 5 stars
$2.16
-0.5%
$5.00
+131.5%
-23.7%$15.10MN/A1.469Short Interest ↑
CYCC
Cyclacel Pharmaceuticals
0.4103 of 5 stars
$6.73
-4.5%
N/A-97.3%$15.08M$10K-0.0114Short Interest ↑
ETHZ
Flag Ship Acquisition
N/A$2.47
+1.2%
N/AN/A$14.92MN/A-0.167News Coverage
Gap Up
COCP
Cocrystal Pharma
2.2617 of 5 stars
$1.45
-3.3%
$6.00
+313.8%
-14.4%$14.88MN/A-1.1710News Coverage
Short Interest ↑
Gap Down

Related Companies and Tools


This page (NASDAQ:EVAX) was last updated on 9/16/2025 by MarketBeat.com Staff
From Our Partners